Vaccines against Plasmodium vivax: a research challenge.

Manuel A. Patarroyo, Dayana Calderón, Darwin A. Moreno-Pérez

Research output: Contribution to journalReview articlepeer-review

28 Scopus citations


Malaria caused by Plasmodium vivax continues being a public health problem in tropical and subtropical areas throughout the whole world. In spite of this species' epidemiological importance, its biological complexity has hampered advances being made in the field of vaccine development. Few antigens have been described and analyzed to date in preclinical and clinical studies, thereby highlighting the great challenge facing groups currently working on this parasite species. This review summarizes the most representative work done during the last few years and discusses the approaches adopted in making progress towards an anti-Plasmodium vivax vaccine.

Original languageEnglish (US)
Pages (from-to)1249-1260
Number of pages12
JournalExpert Review of Vaccines
Issue number10
StatePublished - Oct 2012

All Science Journal Classification (ASJC) codes

  • Immunology
  • Molecular Medicine
  • Pharmacology
  • Drug Discovery


Dive into the research topics of 'Vaccines against Plasmodium vivax: a research challenge.'. Together they form a unique fingerprint.

Cite this